INOTUZUMAB OZOGAMICIN for Diffuse large b-cell lymphoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 88 adverse event reports in the FDA FAERS database where INOTUZUMAB OZOGAMICIN was used for Diffuse large b-cell lymphoma.
Most Reported Side Effects for INOTUZUMAB OZOGAMICIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 253 | 10.9% | 253 | 14 |
| Febrile neutropenia | 230 | 9.9% | 36 | 174 |
| Venoocclusive liver disease | 229 | 9.9% | 114 | 72 |
| Neoplasm progression | 158 | 6.8% | 104 | 26 |
| Pyrexia | 151 | 6.5% | 34 | 109 |
| Off label use | 146 | 6.3% | 63 | 38 |
| Sepsis | 119 | 5.1% | 75 | 55 |
| Venoocclusive disease | 109 | 4.7% | 44 | 37 |
| Thrombocytopenia | 108 | 4.7% | 23 | 47 |
| Platelet count decreased | 107 | 4.6% | 31 | 66 |
| Drug ineffective | 92 | 4.0% | 39 | 27 |
| Neutropenia | 90 | 3.9% | 33 | 33 |
| Cytokine release syndrome | 84 | 3.6% | 24 | 38 |
| Pneumonia | 83 | 3.6% | 39 | 52 |
| Blood bilirubin increased | 77 | 3.3% | 23 | 36 |
Other Indications for INOTUZUMAB OZOGAMICIN
Acute lymphocytic leukaemia (948)
B-cell type acute leukaemia (210)
Acute lymphocytic leukaemia recurrent (170)
B precursor type acute leukaemia (104)
Product used for unknown indication (100)
Non-hodgkin's lymphoma (56)
Acute lymphocytic leukaemia refractory (31)
Precursor b-lymphoblastic lymphoma (19)
Acute leukaemia (15)
Leukaemia (14)
Other Drugs Used for Diffuse large b-cell lymphoma
RITUXIMAB (22,275)
CYCLOPHOSPHAMIDE (16,598)
DOXORUBICIN (15,213)
VINCRISTINE (14,922)
PREDNISONE (11,266)
LENALIDOMIDE (7,858)
ETOPOSIDE (4,698)
PREDNISOLONE (4,086)
CYTARABINE (3,857)
DEXAMETHASONE (3,696)